Yuki Aoi

1.6k total citations
32 papers, 991 citations indexed

About

Yuki Aoi is a scholar working on Molecular Biology, Nuclear and High Energy Physics and Astronomy and Astrophysics. According to data from OpenAlex, Yuki Aoi has authored 32 papers receiving a total of 991 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 7 papers in Nuclear and High Energy Physics and 6 papers in Astronomy and Astrophysics. Recurrent topics in Yuki Aoi's work include Genomics and Chromatin Dynamics (16 papers), RNA Research and Splicing (11 papers) and RNA and protein synthesis mechanisms (8 papers). Yuki Aoi is often cited by papers focused on Genomics and Chromatin Dynamics (16 papers), RNA Research and Splicing (11 papers) and RNA and protein synthesis mechanisms (8 papers). Yuki Aoi collaborates with scholars based in United States, Japan and United Kingdom. Yuki Aoi's co-authors include Ali Shilatifard, Emily J. Rendleman, Edwin R. Smith, Ramin Shiekhattar, Avani P. Shah, Stacy A. Marshall, Shigehiro A. Kawashima, Fei Chen, Ashley R. Woodfin and Anda Zhang and has published in prestigious journals such as Science, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Yuki Aoi

29 papers receiving 985 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuki Aoi United States 16 895 70 66 60 55 32 991
Tsuyoshi Imasaki Japan 14 679 0.8× 43 0.6× 107 1.6× 62 1.0× 16 0.3× 23 764
Junji Otani Japan 14 655 0.7× 49 0.7× 91 1.4× 38 0.6× 28 0.5× 22 739
Konstantinos Tripsianes Czechia 18 794 0.9× 82 1.2× 89 1.3× 56 0.9× 37 0.7× 32 942
Suzanne Sanford United States 9 823 0.9× 76 1.1× 53 0.8× 50 0.8× 12 0.2× 9 895
Colin M. Hammond United Kingdom 8 664 0.7× 58 0.8× 36 0.5× 68 1.1× 12 0.2× 10 752
Maarten Jacquemyn Belgium 11 457 0.5× 94 1.3× 46 0.7× 17 0.3× 21 0.4× 19 610
Thomas Monecke Germany 12 739 0.8× 56 0.8× 29 0.4× 15 0.3× 17 0.3× 22 805
Colin W. Garvie United States 15 785 0.9× 187 2.7× 35 0.5× 25 0.4× 50 0.9× 22 953
Shintaro Aibara Sweden 19 906 1.0× 65 0.9× 36 0.5× 34 0.6× 21 0.4× 33 982
J. Eugene Lee South Korea 9 479 0.5× 96 1.4× 84 1.3× 30 0.5× 25 0.5× 14 590

Countries citing papers authored by Yuki Aoi

Since Specialization
Citations

This map shows the geographic impact of Yuki Aoi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuki Aoi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuki Aoi more than expected).

Fields of papers citing papers by Yuki Aoi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuki Aoi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuki Aoi. The network helps show where Yuki Aoi may publish in the future.

Co-authorship network of co-authors of Yuki Aoi

This figure shows the co-authorship network connecting the top 25 collaborators of Yuki Aoi. A scholar is included among the top collaborators of Yuki Aoi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuki Aoi. Yuki Aoi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kim, Wonho, Marta Iwanaszko, Yuki Aoi, et al.. (2025). MeCP2 interacts with the super elongation complex to regulate transcription. Science Advances. 11(48). eadt5937–eadt5937.
2.
Aoi, Yuki, et al.. (2025). SPT5 regulates RNA polymerase II stability via Cullin 3–ARMC5 recognition. Science Advances. 11(4). eadt5885–eadt5885.
3.
Cenik, Bercin Kutluk, Yuki Aoi, Marta Iwanaszko, et al.. (2024). TurboCas: A method for locus-specific labeling of genomic regions and isolating their associated protein interactome. Molecular Cell. 84(24). 4929–4944.e8. 3 indexed citations
4.
Morgan, Marc A., Marta Iwanaszko, Yuki Aoi, et al.. (2023). ELOA3 : A primate-specific RNA polymerase II elongation factor encoded by a tandem repeat gene cluster. Science Advances. 9(47). eadj1261–eadj1261. 1 indexed citations
5.
Iwanaszko, Marta, Yuki Aoi, Miriam Walter, et al.. (2023). Enhancing HIV-1 latency reversal through regulating the elongating RNA Pol II pause-release by a small-molecule disruptor of PAF1C. Science Advances. 9(10). eadf2468–eadf2468. 13 indexed citations
6.
Aoi, Yuki & Ali Shilatifard. (2023). Transcriptional elongation control in developmental gene expression, aging, and disease. Molecular Cell. 83(22). 3972–3999. 37 indexed citations
7.
Zhao, Zibo, Yuki Aoi, Khyati Meghani, et al.. (2023). Somatic mutations of MLL4/COMPASS induce cytoplasmic localization providing molecular insight into cancer prognosis and treatment. Proceedings of the National Academy of Sciences. 120(52). e2310063120–e2310063120. 6 indexed citations
8.
Aoi, Yuki, Avani P. Shah, Byoung-Kyu Cho, et al.. (2022). SPT6 functions in transcriptional pause/release via PAF1C recruitment. Molecular Cell. 82(18). 3412–3423.e5. 45 indexed citations
9.
daSilva, Lucas F., Ezra Blumenthal, Felipe Beckedorff, et al.. (2021). Integrator enforces the fidelity of transcriptional termination at protein-coding genes. Science Advances. 7(45). eabe3393–eabe3393. 27 indexed citations
10.
Zheng, Bin, Yuki Aoi, Avani P. Shah, et al.. (2021). Acute perturbation strategies in interrogating RNA polymerase II elongation factor function in gene expression. Genes & Development. 35(3-4). 273–285. 36 indexed citations
11.
Beckedorff, Felipe, Ezra Blumenthal, Lucas F. daSilva, et al.. (2020). The Human Integrator Complex Facilitates Transcriptional Elongation by Endonucleolytic Cleavage of Nascent Transcripts. Cell Reports. 32(3). 107917–107917. 82 indexed citations
12.
Aoi, Yuki, Edwin R. Smith, Avani P. Shah, et al.. (2020). NELF Regulates a Promoter-Proximal Step Distinct from RNA Pol II Pause-Release. Molecular Cell. 78(2). 261–274.e5. 112 indexed citations
13.
Tsujii, N., S. Yajima, Y. Takase, et al.. (2019). Measurement of the Lower Hybrid Wave Using RF Magnetic Probes on the TST-2 Spherical Tokamak. Plasma and Fusion Research. 14(0). 3402107–3402107. 2 indexed citations
14.
Martín, Glòria Mas, Enrique Blanco, Cecilia Ballaré, et al.. (2018). Promoter bivalency favors an open chromatin architecture in embryonic stem cells. Nature Genetics. 50(10). 1452–1462. 93 indexed citations
15.
Liang, Kaiwei, Edwin R. Smith, Yuki Aoi, et al.. (2018). Targeting Processive Transcription Elongation via SEC Disruption for MYC-Induced Cancer Therapy. Cell. 175(3). 766–779.e17. 86 indexed citations
16.
Ishiguro, Tadashi, Yoshifumi Amamoto, Kana Tanabe, et al.. (2017). Synthetic Chromatin Acylation by an Artificial Catalyst System. Chem. 2(6). 840–859. 28 indexed citations
17.
Kawashima, Shigehiro A., Zhen Chen, Yuki Aoi, et al.. (2016). Potent, Reversible, and Specific Chemical Inhibitors of Eukaryotic Ribosome Biogenesis. Cell. 167(2). 512–524.e14. 51 indexed citations
18.
Aoi, Yuki, Masamitsu Sato, Takashi Sutani, et al.. (2014). Dissecting the first and the second meiotic divisions using a marker-less drug-hypersensitive fission yeast. Cell Cycle. 13(8). 1327–1334. 18 indexed citations
19.
Aoi, Yuki, Shigehiro A. Kawashima, Viesturs Simanis, Masayuki Yamamoto, & Masamitsu Sato. (2014). Optimization of the analogue-sensitive Cdc2/Cdk1 mutant byin vivoselection eliminates physiological limitations to its use in cell cycle analysis. Open Biology. 4(7). 140063–140063. 33 indexed citations
20.
Aoi, Yuki, et al.. (2013). Cuf2 boosts the transcription of APC/C activator Fzr1 to terminate the meiotic division cycle. EMBO Reports. 14(6). 553–560. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026